Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of 48-week treatment with
Clevudine 30 mg qd versus lamivudine 100 mg qd for chronic hepatitis B infection.